News | 07 December 2023
Lupin receives approval from U.S. FDA for Varenicline Tablets
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
GMM Pfaudler US completes acquisition of MixPro
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The product has been in-licensed from Strides and will be commercialized by Amneal
The company has received Form 483 with three observations
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Both the India and GCC entities will be operated by separate dedicated management teams
Subscribe To Our Newsletter & Stay Updated
